Epithelial stem cell mutations that promote Squamous cell carcinoma metastasis

Journal of Clinical Investigation

Volumn 123, Issue 10, 2013, Pages 4390-4404

  White, Ruth A ^a,b   Neiman, Jill M ^a   Reddi, Anand ^a   Han, Gangwen ^a   Birlea, Stanca ^a   Mitra, Doyel ^a   Dionne, Laikuan ^a   Fernandez, Pam ^a   Murao, Kazutoshi ^a,c   Bian, Li ^a,d   Keysar, Stephen B ^a   Goldstein, Nathaniel B ^a   Song, Ningjing ^e   Bornstein, Sophia ^b   Han, Zheyi ^a   Lu, Xian ^f   Wisell, Joshua ^a   Li, Fulun ^a   Song, John ^a   Lu, Shi Long ^a,c   Jimeno, Antonio ^a,c   Roop, Dennis R ^a,c   Wang, Xiao Jing ^a,c   more..

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d KUNMING MEDICAL UNIVERSITY   (China)

^e Shanghai Skin Disease Hospital   (China)

^f Biostatistics and Informatics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; ASPARTIC ACID; CYTOKERATIN 15; DOCETAXEL; GLYCINE; K RAS PROTEIN; MICRORNA 9; MIFEPRISTONE; SMAD4 PROTEIN; UVOMORULIN; VERAPAMIL; KRAS PROTEIN, HUMAN; MICRORNA; MIRN92 MICRORNA, HUMAN; ONCOPROTEIN; RAS PROTEIN; SMAD4 PROTEIN, HUMAN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STEM CELL; CELL INVASION; CELL POPULATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIAL STEM CELL; EPITHELIUM CELL; GENE DELETION; GENE EXPRESSION; GENE LOSS; GENE MUTATION; GENE TARGETING; GROWTH INHIBITION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; LUNG METASTASIS; MOUSE; NONHUMAN; ONCOGENE; PRIMARY TUMOR; PRIORITY JOURNAL; SIDE POPULATION CELL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; STEM CELL; STEM CELL EXPANSION; TRANSGENIC ANIMAL; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL DEDIFFERENTIATION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MISSENSE MUTATION; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; SECONDARY; SKIN TUMOR; TRANSGENIC MOUSE; TUMOR CELL CULTURE;

ALPHA CATENIN; ANIMALS; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL DEDIFFERENTIATION; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; MICE, TRANSGENIC; MICRORNAS; MUTATION, MISSENSE; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RNA INTERFERENCE; SEQUENCE DELETION; SIDE-POPULATION CELLS; SKIN NEOPLASMS; SMAD4 PROTEIN; TUMOR CELLS, CULTURED;

EID: 84885064479     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI65856     Document Type: Article

References (66)

1. Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg. 2007;33(8):885-899.
2. Friedman HI, Cooper PH, Wanebo HJ. Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer. 1985;56(5):1099-1105.
3. Ratushny V, Gober MD, Hick R, Ridky TW, Seykora JT. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest. 2012;122(2):464-472.
4. Bornstein S, et al. Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J Clin Invest. 2009;119(11):3408-3419.
5. Qiao W, Li AG, Owens P, Xu X, Wang XJ, Deng CX. Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin. Oncogene. 2006;25(2):207-217.
6. Teng Y, et al. Synergistic function of Smad4 and PTEN in suppressing forestomach squamous cell carcinoma in the mouse. Cancer Res. 2006;66(14):6972-6981.
7. Hsu YC, Fuchs E. A family business: stem cell progeny join the niche to regulate homeostasis. Nat Rev Mol Cell Biol. 2012;13(2):103-114.
8. Arwert EN, Hoste E, Watt FM. Epithelial stem cells, wound healing and cancer. Nat Rev Cancer. 2012;12(3):170-180.
9. Tudor D, Locke M, Owen-Jones E, Mackenzie IC. Intrinsic patterns of behavior of epithelial stem cells. J Investig Dermatol Symp Proc. 2004;9(3):208-214.
10. Shendrik I, Crowson AN, Magro CM. Follicular cutaneous squamous cell carcinoma: an underrecognized neoplasm arising from hair appendage structures. Br J Dermatol. 2013;169(2):384-388.
11. Liu Y, Lyle S, Yang Z, Cotsarelis G. Keratin 15 promoter targets putative epithelial stem cells in the hair follicle bulge. J Invest Dermatol. 2003;121(5):963-968.
12. Jackson EL, et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 2001;15(24):3243- 3248.
13. Li S, et al. A keratin 15 containing stem cell population from the hair follicle contributes to squamous papilloma development in the mouse [published online ahead of print March 16, 2012]. Mol Carcinog. doi:10. 1002/mc. 21896.
14. Lapouge G, et al. Identifying the cellular origin of squamous skin tumors. Proc Natl Acad Sci U S A. 2011;108(18):7431-7436.
15. White AC, et al. Defining the origins of Ras/p53-mediated squamous cell carcinoma. Proc Natl Acad Sci U S A. 2011;108(18):7425-7430.
16. Wang GY, Wang J, Mancianti ML, Epstein EH. Basal cell carcinomas arise from hair follicle stem cells in Ptch1 (+/-) mice. Cancer Cell. 2011;19(1):114-124.
17. Chaffer CL, et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A. 2011;108(19):7950-7955.
18. Mani SA, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704-715.
19. Trempus CS, et al. Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34. J Invest Dermatol. 2003;120(4):501-511.
20. Schober M, Fuchs E. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-beta and integrin/focal adhesion kinase (FAK) signaling. Proc Natl Acad Sci U S A. 2011;108(26):10544-10549.
21. Hirschmann-Jax C, et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A. 2004;101(39):14228-14233.
22. Redvers RP, Li A, Kaur P. Side population in adult murine epidermis exhibits phenotypic and functional characteristics of keratinocyte stem cells. Proc Natl Acad Sci U S A. 2006;103(35):13168-13173.
23. Liang L, Bickenbach JR. Somatic epidermal stem cells can produce multiple cell lineages during development. Stem Cells. 2002;20(1):21-31.
24. Song J, Chang I, Chen Z, Kang M, Wang CY. Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling. PLoS One. 2010;5(7):e11456.
25. Lu SL, et al. Loss of transforming growth factor-beta type II receptor promotes metastatic headand-neck squamous cell carcinoma. Genes Dev. 2006;20(10):1331-1342.
26. Hoot KE, et al. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest. 2008;118(8):2722-2732.
27. Katiyar SK, Matsui MS, Mukhtar H. Kinetics of UV light-induced cyclobutane pyrimidine dimers in human skin in vivo: an immunohistochemical analysis of both epidermis and dermis. Photochem Photobiol. 2000;72(6):788-793.
28. Hanasoge S, Ljungman M. H2AX phosphorylation after UV irradiation is triggered by DNA repair intermediates and is mediated by the ATR kinase. Carcinogenesis. 2007;28(11):2298-2304.
29. Morris RJ, et al. Capturing and profiling adult hair follicle stem cells. Nat Biotechnol. 2004;22(4):411-417.
30. Lu SL, et al. Loss of transforming growth factor-beta type II receptor promotes metastatic head-andneck squamous cell carcinoma. Genes Dev. 2006;20(10):1331-1342.
31. Mukhopadhyay A, Krishnaswami SR, Yu BD. Activated Kras alters epidermal homeostasis of mouse skin, resulting in redundant skin and defective hair cycling. J Invest Dermatol. 2011;131(2):311-319.
32. Yang L, et al. Targeted disruption of Smad4 in mouse epidermis results in failure of hair follicle cycling and formation of skin tumors. Cancer Res. 2005;65(19):8671-8678.
33. Blanpain C, Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol. 2009;10(3):207-217.
34. Boyd AS, Stasko TS, Tang YW. Basaloid squamous cell carcinoma of the skin. J Am Acad Dermatol. 2011;64:144-151.
35. Prince ME, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007;104(3):973-978.
36. Biddle A, et al. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res. 2011;71(15):5317-5326.
37. Lichti U, Anders J, Yuspa SH. Isolation and shortterm culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat Protoc. 2008;3(5):799-810.
38. Yi R, et al. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat Genet. 2006;38(3):356-362.
39. Dean M. The genetics of ATP-binding cassette transporters. Methods Enzymol. 2005;400:409-429.
40. Bornstein S, et al. Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J Clin Invest. 2009;119(11):3408-3419.
41. Ma L, et al. miR-9, a MYC/MYCN-activated micro-RNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010;12(3):247-256.
42. Tsai KW, et al. Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics. 2011;6(10):1189-1197.
43. Heller G, et al. Genome-wide microRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers. Clin Cancer Res. 2012;18(6):1619-1629.
44. Minor J, et al. Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncol. 2012;48(1):73-78.
45. Wan HY, Guo LM, Liu T, Liu M, Li X, Tang H. Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer. 2010;9:16.
46. Guo LM, et al. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J. 2009;276(19):5537-5546.
47. Zhuang G, et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J. 2012;31(17):3513-3523.
48. Chen D, et al. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat Med. 2012;18(10):1511-1517.
49. Zhu L, et al. MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. Med Oncol. 2012;29(2):1037-1043.
50. Goto M, et al. Rap1 stabilizes beta-catenin and enhances beta-catenin-dependent transcription and invasion in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2010;16(1):65-76.
51. Rodriguez-Pinilla M, et al. β-Catenin, Nf-κB and FAS protein expression are independent events in head and neck cancer: study of their association with clinical parameters. Cancer Lett. 2005;230(1):141-148.
52. Chikazawa N, et al. Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells. Anticancer Res. 2010;30(6):2041-2048.
53. Yamada T, et al. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/β-catenin complex in early colorectal carcinogenesis. Cancer Res. 2000;60(17):4761-4766.
54. Suzuki A, et al. Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res. 2003;63(3):674-681.
55. Ito M, et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med. 2005;11(12):1351-1354.
56. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature. 2008;456(7222):593-598.
57. Herrero JI, et al. Nonmelanoma skin cancer after liver transplantation. Study of risk factors. Liver Transpl. 2005;11(9):1100-1106.
58. Dlugosz A, Merlino G, Yuspa SH. Progress in cutaneous cancer research. J Investig Dermatol Symp Proc. 2002;7(1):17-26.
59. Hildebrandt MA, et al. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene. 2010;29(42):5724-5728.
60. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449(7163):682-688.
61. Kobielak A, Fuchs E. Links between a-catenin, NF-kB, and squamous cell carcinoma in skin. Proc Natl Acad Sci U S A. 2006;103(7):2322-2327.
62. Schlegelmilch K, et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell. 2011;144(5):782-795.
63. Myers JN, Holsinger FC, Jasser SA, Bekele BN, Fidler IJ. An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res. 2002;8:293-298.
64. Go C, et al. Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFβRII. Oncogene. 2000;19(32):3623-3631.
65. Li AG, Wang D, Feng XH, Wang XJ. Latent TGFβ1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J. 2004;23(8):1770-1781.
66. Lakos G, et al. Targeted disruption of TGF-β/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol. 2004;165(1):203-217